
Efficacy of CIDP Treatments Immunoglobulin 10% and Efgartigimod Compared Through Matching-Adjusted Indirect Analysis
In a newly presented matching-adjusted indirect comparison (MAIC), researchers evaluated the efficacy of immunoglobulin (IVIg) subcutaneous (SC) 10% solution maintenance therapy (Panzyga; Pfizer) compared with SC efgartigimod (Vyvgart Hytrulo; Argenx) in …